Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells

INTRODUCTION: Hepatocellular carcinoma (HCC) is the most common form of hepatic malignancy in the world. We aimed to determine the effect of tanshinone IIA (Tan-IIA) in combination with sorafenib or its derivative SC-1 on cytotoxicity, apoptosis, and metastasis in human HCC cells. MATERIALS AND METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Chien-Ming, Huang, Sung-Ying, Chang, Shu-Fang, Liao, Kuan-Fu, Chiu, Sheng-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881525/
https://www.ncbi.nlm.nih.gov/pubmed/29636623
http://dx.doi.org/10.2147/OTT.S161534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881525/
https://www.ncbi.nlm.nih.gov/pubmed/29636623
http://dx.doi.org/10.2147/OTT.S161534

Ejemplares similares